Artelo Biosciences Inc

ARTL

Company Profile

  • Business description

    Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

  • Contact

    505 Lomas Santa Fe
    Suite 160
    Solana BeachCA92075
    USA

    T: +1 858 925-7049

    https://www.artelobio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    6

Stocks News & Analysis

stocks

Earnings winners: WOW, WTC and FMG set the tone

The ASX companies that closed out earnings season with a bang.
stocks

Do dividends build or limit wealth creation?

In this episode of Investing Compass, we talk to James Gruber about why he dislikes dividend stocks.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,435.6015.100.16%
CAC 408,580.7540.18-0.47%
DAX 4025,284.264.76-0.02%
Dow JONES (US)48,977.92521.28-1.05%
FTSE 10010,910.5563.850.59%
HKSE26,630.54249.520.95%
NASDAQ22,668.21210.17-0.92%
Nikkei 22558,850.2796.880.16%
NZX 50 Index13,722.9752.260.38%
S&P 5006,878.8829.98-0.43%
S&P/ASX 2009,198.6016.900.18%
SSE Composite Index4,162.8816.250.39%

Market Movers